PUBLISHED-SEQUENCE ANTIBODY · SC-PSA-0222

Budigalimab antibody

PD-1 / PDCD1 / CD279

Available by inquiry

Budigalimab is a research antibody reference targeting PD-1 / PDCD1 / CD279. Pure and fluorescently conjugated formats are available by inquiry.

Catalog number
SC-PSA-0222
Target
PD-1 / PDCD1 / CD279
Available formats
Pure or fluorescently conjugated
Research use
For research use only

Product information

Available labeling options

Pure · Biotin · BV421 · V450 · V500 · AF488 · PerCP-Cy5.5 · PE · AF594 · PE-Cy5 · PE-Cy7 · APC · AF700 · APC-Cy7

Tell us the intended application, amount and preferred label. Final configuration and delivery are confirmed in the quotation.

PUBLIC REFERENCE

Reference source

WHO Recommended INN List 81 (2019)

View reference ↗
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact us
Budigalimab Antibody (PD-1 / PDCD1 / CD279) | StellaCyte